19367293|t|P-glycoprotein and breast cancer resistance protein restrict apical-to-basolateral permeability of human brain endothelium to amyloid-beta.
19367293|a|The clearance of amyloid beta (Abeta) from the brain represents a novel therapeutic target for Alzheimer's disease. Conflicting data exist regarding the contribution of adenosine triphosphate-binding cassette transporters to the clearance of Abeta through the blood-brain barrier. Therefore, we investigated whether Abeta could be a substrate for P-glycoprotein (P-gp) and/or for breast cancer resistance protein (BCRP) using a human brain endothelial cell line, hCMEC/D3. Inhibition of P-gp and BCRP increased apical-to-basolateral, but not basolateral-to-apical, permeability of hCMEC/D3 cells to (125)I Abeta 1-40. Our in vitro data suggest that P-gp and BCRP might act to prevent the blood-borne Abeta 1-40 from entering the brain.
19367293	0	14	P-glycoprotein	Gene	5243
19367293	19	51	breast cancer resistance protein	Gene	9429
19367293	99	104	human	Species	9606
19367293	126	138	amyloid-beta	Gene	351
19367293	157	169	amyloid beta	Gene	351
19367293	171	176	Abeta	Gene	351
19367293	235	254	Alzheimer's disease	Disease	MESH:D000544
19367293	382	387	Abeta	Gene	351
19367293	456	461	Abeta	Gene	351
19367293	487	501	P-glycoprotein	Gene	5243
19367293	503	507	P-gp	Gene	5243
19367293	520	552	breast cancer resistance protein	Gene	9429
19367293	554	558	BCRP	Disease	MESH:D001943
19367293	568	573	human	Species	9606
19367293	603	611	hCMEC/D3	CellLine	CVCL:U985
19367293	627	631	P-gp	Gene	5243
19367293	636	640	BCRP	Disease	MESH:D001943
19367293	721	729	hCMEC/D3	CellLine	CVCL:U985
19367293	739	745	(125)I	Chemical	MESH:C000614960
19367293	789	793	P-gp	Gene	5243
19367293	798	802	BCRP	Disease	MESH:D001943
19367293	Association	MESH:D001943	351
19367293	Association	MESH:D000544	351
19367293	Association	MESH:C000614960	MESH:D001943
19367293	Association	351	5243
19367293	Association	351	9429

